logo
Advanced Bladder Cancer: So Many Drugs, So Little Progress
the Case for Prostate-Specific Antigen Screening Starting at Age 40
Is Patient Performance Status Always An Accurate Surrogate for Predicting Tumor Biology in Patients With Metastatic Renal Cancer?
Advanced Bladder Cancer: Status of First-Line Chemotherapy and the Search for Active Agents in the Second-Line Setting
Serum Her-2/ Neu and Relative Resistance to Trastuzumab-Based Therapy in Patients With Metastatic Breast Cancer
Influence of Induction Chemotherapy and Class of Cytotoxics on Pathologic Response and Survival After Preoperative Chemoradiation in Patients With Carcinoma of the Esophagus
Sunitinib-Induced Macrocytosis in Patients With Metastatic Renal Cell Carcinoma
Prostate-Specific Antigen Screening Among Young Men in the United States
Performance Status and Cytoreductive Nephrectomy
Triplet Combination of Gemcitabine, Paclitaxel, and Carboplatin Followed by Maintenance 5-Fluorouracil and Folinic Acid in Patients With Metastatic Nasopharyngeal Carcinoma
the Effect of Interleukin 11 on Thrombocytopenia Associated With Tyrosine Kinase Inhibitor Therapy in Patients With Chronic Myeloid Leukemia
High-Dose Therapy and Autologous Stem Cell Transplantation for Chemoresistant Hodgkin Lymphoma
Proposal for A New Risk Model in Myelodysplastic Syndrome That Accounts for Events Not Considered in the Original International Prognostic Scoring System
Successful Management of Severe L-Asparaginase–Associated Pancreatitis by Continuous Regional Arterial Infusion of Protease Inhibitor and Antibiotic
Myeloid Sarcoma Is Associated With Superior Event-Free Survival and Overall Survival Compared With Acute Myeloid Leukemia
Ercc1 Expression As A Prognostic Marker in N2(+) Nonsmall-Cell Lung Cancer Patients Treated With Platinum-Based Neoadjuvant Concurrent Chemoradiotherapy
Predominant Infiltration of Macrophages and Cd8+ T Cells in Cancer Nests Is A Significant Predictor of Survival in Stage Iv Nonsmall Cell Lung Cancer
Clinical Significance of Aberrant Methylation of Prostaglandin E Receptor 2 ( Ptger2 ) in Nonsmall Cell Lung Cancer
Combined Treatment With Pegylated Interferon–α-2A and Dacarbazine in Patients With Advanced Metastatic Melanoma
Identification of Low Intratumoral Gene Expression Heterogeneity in Neuroblastic Tumors by Genome-Wide Expression Analysis and Game Theory
Cancer Health Disparities Among Indian and Pakistani Immigrants in the United States
Racial Disparities in Recurrence Among Patients With Early-Stage Endometrial Cancer
Zoledronic Acid and Skeletal Complications in Patients With Solid Tumors and Bone Metastases
Evaluating the Supportive Care Costs of Severe Radiochemotherapy-Induced Mucositis and Pharyngitis
Copy Number Gains in Egfr and Copy Number Losses in Pten Are Common Events in Osteosarcoma Tumors
A Randomized Study Assessing the Efficacy of Communication Skill Training on Patients' Psychologic Distress and Coping
Perceptions of Cancer-Related Information Among Cancer Survivors: A Report From the American Cancer Society'S Studies of Cancer Survivors
Development of A Fatigue and Functional Impact Scale in Anemic Cancer Patients Receiving Chemotherapy
the Phosphorylated Membrane Estrogen Receptor and Cytoplasmic Signaling and Apoptosis Proteins in Human Breast Cancer